Quality assessment of various brands of Levofloxacin tablets available in Uyo Metropolis
Barre latérale de l'article
Contenu principal de l'article
Résumé
Levofloxacin is a second-generation fluoroquinolone antibacterial agent used for the treatment of a variety of bacterial infections, especially urinary tract infections, and prostitis. Ten brands of levofloxacin were sourced from various pharmacies in Uyo metropolis and subjected to qualitative and quantitative assay using standard physical tests and spectrophotometric method respectively. The standard physical tests done were weight uniformity, hardness, friability, disintegration and dissolution rate. Quantitative assay was by a spectrophotometric measurement of the ion-pair complex of the drug with the sulphonpthalein dye, bromothymol blue (BTB), using chloroform as the solvent. All the brands met the standard for weight uniformity test as they had percentage deviation of less than 5%. All the brands failed the hardness test as they had crushing strength of more than 10Kg/cm2. All brands met the standard for friability test and disintegration test as they had percentage weight losses of less than 1% (w/w) and they all disintegrated in less than 15 minutes. Two brands did not meet the requirement for dissolution rate as they had less than 80% of the drug dissolving in 30 minutes. The spectrophotometric measurement was done at 410mn. The calibration curve for reference levofloxacin was linear over a concentration range of 2.5-40?g/mL and the recovery of the drug ranged between 99.04-100.09%. The ten brands were within the limits specified in the official compendia. The results obtained from these tests gave important information on the standard and batch-to-batch consistency of the evaluated brands. The spectrophotometric assay method is simple and precise for the analysis of levofloxacin in bulk and pharmaceutical dosage forms.
Téléchargements
Renseignements sur l'article
Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.
Références
Altiokka G, Atkosar Z, Can NO (2002). The determination of levofloxacin by flow injection analysis using UV detection, potentiometry, and conductometry in pharmaceutical preparations. J Pharm Biomed Anal., 30(3):881-5.
Chukwuenweniwe JE, Solomon OA, John OA (1997) J. Antimicrobial Chemotherapy 39:639-641
Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ (2005) The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers. PLoS Med 2(4): e100. https://doi.org/10.1371/journal.pmed.0020100 Retrieved 30/03/2020
Drlica K and Khao X. (1997) DNA gyrase, Topoisomerase IV and the 4-quinolones. Microbial Molecular Biology. 61:377-392.
Elbashir AA, Saad B, Ali AS, Saleh MI (2008). Development of a capillary electrophoresis method for the enantioselective estimation of primaquine in pharmaceutical formulations. J AOAC Int.; 91(3):536-41.
El-Brashy A.M., Metwally M.E, El-Sepai FA. (2004). Spectrophotometric determination of some fluoroquinolone antibacterials through charge-transfer and ion-pair complexation reactions. Bulletin of the Korean Chemical Society 25 (3): 365–372.
El-Brashy, A.M., Metwally, M.E, El-Sepai, F.A. (2005). Spectrophotometric determination of some fluoroquinolone antibacterial by ion-pair complex formation with cobalt (II) tetrathiocyanate. Journal of the Chinese Chemical Society, 52: 77–84.
Genazzani A, Pattarino F. (2008). Difficulties in production of identical products from a pharmaceutical technology viewpoint. Drugs R D, 9(2):65–72; doi:10.2165/00126839-200809020-00001
Igboasoiyi A.C., Eseyin O.A., Oladimeji H.O., Akpan RJ (2012). Quality Assessment of Some Brands of Piroxicam Capsules. Nigerian Journal of Pharmaceutical and Applied Science Research, 1(2): 91-97
Issa YM, Abdel-Gawad, FM, Table MA, Hussein H. (1997). Spectrophotometric determination of ofloxacin and levofloxacin hydrochloride with some sulphonphthalein dyes. Analytical Letters 30:2071–2084.
Jaman M, Chowdhury AA, Rana AA, Masum SM, Ferdous T, Rashid MA, Karim. MM (2015). In vitro evaluation of Ciprofloxacin Hydrochloride. Bangladesh J. Sci. Ind. Res. 50(4), 251-256.
Jantratid E., Janssen N, Reppas C, Dressman JB (2008) Dissolution media simulatingconditions in the proximal human gastrointestinal tract: an update. Pharmaceutical Resources. 25:1663-1676.
Joshi S (2002). HPLC separation of antibiotics present in formulated and unformulated samples. Journal of Pharmaceutical and Biomedical Analysis. 28(5):795-809
Meyyanathan SN, Ramasarma GV, Suresh B (2003). Analysis of levofloxacin in pharmaceutical preparations by high performance thin layer chromatography. J. Sep. Sci., 26 (18) 1698–1700.
Moustafa ME, Amin SA, El-Dosoky RMS (2008). Spectrophotometric determination of some quinolone derivatives in dosage forms and biological fluids using ion-pair complex formation. Analytical Letters. 41: 837-852.
Nagaralli BS, Seetharamappa J, Melwanki MB (2002). Sensitive spectrophotometric methods for the determination of amoxycillin, ciprofloxacin and piroxicam in pure and pharmaceutical formulations. J Pharm Biomed Anal., 29(5):859-64.
Ofoefule, S. (2002). A Textbook of Pharmaceutical Technology and Industrial Pharmacy, First edition. Samikin Nigeria Ent. Lagos Nigeria. pp 58-65.
Ragab GH, Amin AS (2004). Atomic absorption spectroscopic, conductometric and colorimetric methods for determination of fluoroquinolone antibiotics using ammonium reineckate ion-pair complex formation. Spectrochim Acta A Mol Biomol Spectrosc., 60(4):973-8.
Salem HA (2005) Spectrophotometric, atomic absorption and spectrometric determination of some fluoroquinolones”. American Journal of Applied Science. 2:719-729.
Salem H., Fada L, Khater, W. (2007). Spectrofluorimetric determination of certain fluoroquinolones through charge transfer complex formation. American Journal of Pharmacology and Toxicology, 2:18–25.
Sastry CPS, Rao KR, and Prasad DS (1995). Spectrophotometric determination of enrofloxacin and ofloxacin in pharmaceutical formulations, Indian Drugs, 32(4):172–175.
Shah VP (2001). Dissolution: a quality control test vs a bioequivalent test. Dissolution Technologies 8(4): 1–2.
Tuncel M and Atkosar Z (1992) The determination of ofloxacin in tablets by potentiometry and conductometry, Pharmazie, 47(8):642–643.
United States Food and Drug Administration, Center for Drug Evaluation and Research (1997). Guidance for industry: Dissolution testing of immediate release solid oral dosage forms, available at: http://www.fda.gov/cder/Guidance/1713bp1.pdf retrieved 30/03/2020.
Voegele, D. (1992) “Drug release in vitro: An aid in clinical trials?” Met. Find. Exp. Clinical Pharmacology. 21:29-39.
World Health Organisation 19th WHO Model List of Essential Medicines, 2015; p.13.